Skip to content

Comparison of techniques for pain relief in patients with pain due to herpes zoster

"Efficacy and comparison of paravertebral vs epidural block for herpetic neuralgia"

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/12/029508
Enrollment
40
Registered
2020-12-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Paravertebral block in herpetic neuralgia patients: paravertebral block will be given in patients with 40mg methylprednisolone plus 50mcg clonidine plus bupivacaine 0.125% total 10ml. C

Sponsors

Indira gandhi medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients of either gender age group 18-60 years weight between 40-80 kg Herpetic neuralgia of 14days to 3months duration Patients should have had atleast 14 days of trial of conventional medical therapy VAS scores of the patient >6 at anytime in 24 hours for justification of intervention Patients with thoracic or lumbar herpes zoster

Exclusion criteria

Exclusion criteria: Those refusing to participate in study Severe cardiac or respiratory diseases Allergic to test drug or local anaesthetics Severe hepatic impairment Bleeding disorders (Bleeding time, Clotting time will be undertaken) Patients on therapeutic anti coagulants Local site infection

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of epidural vs paravertebral block in providing analgesia in herpetic neuralgia patients using VAS scoresTimepoint: patients will be followed up on alternate days for VAS score, Quality of life scale and satisfaction score for 10 days either clinically or telephonically.( Day 3,5,7 & 10)

Secondary

MeasureTime frame
To compare the patient satisfaction score in both the groups using likert scale To compare the quality of life scale in both the groups using American chronic pain association scales To study the side effect profile of both the blocks in these patientsTimepoint: patients will be followed up on alternate days for VAS score, Quality of life scale and satisfaction score for 10 days either clinically or telephonically.( Day 3,5,7 & 10)In all the scales an average score in last 24hrs will be recorded.

Countries

India

Contacts

Public ContactDr kartik syal

Indira gandhi medical college and hospital

drrajeshkverma@gmail.com9418077248

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026